Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · STATUTE-COMPILATIONS · Sunscreen Innovation Act · Sec. 3

Sec. 3. NON-SUNSCREEN TIME AND EXTENT APPLICATIONS

1,688 words·~8 min read·/statute-compilations/comps-11320/sec-3

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 3 NON-SUNSCREEN TIME AND EXTENT APPLICATIONS Subchapter I of chapter V of the Federal Food, Drug, and Cosmetic Act, as added by section 2, is amended by adding at the end the following: > > ## “SEC. 586F NON-SUNSCREEN TIME AND EXTENT APPLICATIONS > > **[**[21 U.S.C. 360fff-6](/us/usc/t21/s360fff-6)**]** > > > ### “(a) Pending Time and Extent Applications > > > #### “(1) In general > > > ##### “(A) Request for framework for review > > If, prior to the date of enactment of the Sunscreen Innovation Act, an application was submitted pursuant to section 330.14 of title 21, Code of Federal Regulations for a GRASE determination for a drug other than a nonprescription sunscreen active ingredient or combination of nonprescription sunscreen active ingredients and such drug was found to be eligible to be considered for inclusion in the over-the-counter drug monograph system pursuant to section 330.14 of title 21, Code of Federal Regulations, the sponsor of such application may request that the Secretary provide a framework under paragraph
(2)for the review of such application. > > > ##### “(B) Request requirements > > A request for a framework for review of an application made under subparagraph
(A)shall be made within 180 calendar days of the date of enactment of the Sunscreen Innovation Act and shall include the preference of such sponsor as to whether such application is reviewed by the Secretary in accordance with— > > > ###### “(i) > > the processes and procedures set forth for pending requests under section 586C(b), except that specific timelines shall be determined in accordance with other applicable requirements under this section; > > > ###### “(ii) > > the processes and procedures set forth under part 330 of title 21, Code of Federal Regulations (or any successor regulations); > > > ###### “(iii) > > an initial filing determination under the processes and procedures described in section 586B(b) and the processes and procedures set forth for pending requests under section 586C(b), except that specific timelines shall be determined in accordance with other applicable requirements under this section; or > > > ###### “(iv) > > an initial filing determination under the processes and procedures described in section 586B(b) and the processes and procedures set forth under part 330 of title 21, Code of Federal Regulations (or any successor regulations). > > > ##### “(C) No request > > If a sponsor described in subparagraph
(A)does not make such request within 180 calendar days of the date of enactment of the Sunscreen Innovation Act, such application shall be reviewed by the Secretary in accordance with the timelines of the applicable regulations when such regulations are finalized under subsection (b). > > > #### “(2) Framework > > Not later than 1 year after the date of enactment of the Sunscreen Innovation Act, the Secretary shall provide, in writing, a framework to each sponsor that submitted a request under paragraph (1). Such framework shall set forth the various timelines, in calendar days, with respect to the processes and procedures for review under clauses (i), (ii), (iii), and
(iv)of paragraph (1)(B) and— > > > ##### “(A) > > such timelines shall account for the considerations under paragraph (5); and > > > ##### “(B) > > the timelines for the various processes and procedures shall not be shorter than the timelines set forth for pending requests under sections 586B(b) and 586C(b), as applicable. > > > #### “(3) Governing processes and procedures for review > > > ##### “(A) Election > > Not later than 60 calendar days after the Secretary provides a framework to a sponsor under paragraph (2), such sponsor may provide an election to the Secretary regarding the processes and procedures for review under clause (i), (ii), (iii), or
(iv)of paragraph (1)(B). If such sponsor makes such election, the Secretary shall review the application that is the subject of such election pursuant to the processes and procedures elected by such sponsor and the applicable timelines in calendar days set forth under such framework, which the Secretary shall confirm in writing to the sponsor not later than the date upon which the Secretary provides a report under paragraph (4). If such sponsor does not make such election, such application shall be reviewed by the Secretary in accordance with the timelines of the applicable regulations when such regulations are finalized under subsection (b). > > > ##### “(B) Different processes and procedures > > At any time during review of an application, the Secretary may review such application under different processes and procedures under clause (i), (ii), (iii), or
(iv)of paragraph (1)(B) than the processes and procedures the sponsor elected in accordance with subparagraph (A), so long as the Secretary proposes, in writing, the change and the sponsor agrees, in writing, to such change. > > > ##### “(C) Inclusion of ingredients in monographs > > If the sponsor elects to use the processes and procedures for review in accordance with clause
(i)or
(iii)of paragraph (1)(B), the Secretary may incorporate any resulting final order into a regulation addressing the conditions under which other drugs in the same therapeutic category are GRASE and not misbranded, including through direct final rulemaking, and the final order so incorporated shall cease to be effective on the effective date of the final regulation that addresses such drug. > > > #### “(4) Letter regarding pending applications > > Not later than 18 months after the date of enactment of the Sunscreen Innovation Act, the Secretary shall report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, in writing, regarding all pending applications subject to paragraph (1). In such letter, the Secretary shall provide a report on the review of such applications, including the timelines, in calendar days, for the review and GRASE determination for each application. Such timelines shall account for the considerations under paragraph (5). > > > #### “(5) Timelines > > The timelines in calendar days established by the Secretary pursuant to this subsection— > > > ##### “(A) > > may vary based on the content, complexity, and format of the application submitted to the Secretary; and > > > ##### “(B) > > shall— > > > ###### “(i) > > reflect the public health priorities of the Food and Drug Administration, including the potential public health benefits posed by the inclusion of additional drugs in the over-the-counter drug monograph system; > > > ###### “(ii) > > take into consideration the resources available to the Secretary for carrying out such priorities and the processes and procedures described in paragraphs (1)(B) and (2); and > > > ###### “(iii) > > be reasonable, taking into consideration the requirements described in clauses
(i)and (ii). > > > ### “(b) New Time and Extent Applications > > > #### “(1) In general > > Not later than 18 months after the date of enactment of the Sunscreen Innovation Act, the Secretary shall issue proposed regulations establishing timelines for the review of applications for GRASE determinations for drugs other than nonprescription sunscreen active ingredients or combinations of nonprescription sunscreen active ingredients that are submitted to the Secretary after the date of enactment of the Sunscreen Innovation Act, under section 330.14 of title 21, Code of Federal Regulations (or any successor regulations), and that are found to be eligible to be considered for inclusion in the over-the-counter drug monograph system pursuant to section 330.14 of title 21, Code of Federal Regulations (or any successor regulations), or that are subject to this subsection pursuant to paragraph
(1)or
(3)of subsection (a), as applicable, providing— > > > ##### “(A) > > timely and efficient completion of evaluations of applications under section 330.14 of title 21, Code of Federal Regulations (or any successor regulations) for drugs other than sunscreens; and > > > ##### “(B) > > timely and efficient completion of the review of the safety and effectiveness submissions pursuant to such applications, including establishing— > > > ###### “(i) > > reasonable timelines, in calendar days, for the applicable proposed and final regulations for applications of various content, complexity, and format, and timelines for internal procedures related to such processes; and > > > ###### “(ii) > > measurable metrics for tracking the extent to which the timelines set forth in the regulations are met. > > > #### “(2) Timelines > > The timelines in calendar days established in the regulations under paragraph (1)— > > > ##### “(A) > > may vary based on the content, complexity, and format of the application submitted to the Secretary; and > > > ##### “(B) > > shall— > > > ###### “(i) > > reflect the public health priorities of the Food and Drug Administration, including the potential public health benefits posed by the inclusion of additional drugs in the over-the-counter drug monograph system; > > > ###### “(ii) > > take into consideration the resources available to the Secretary for carrying out such priorities and the processes and procedures described in paragraph (1); and > > > ###### “(iii) > > be reasonable, taking into consideration the requirements described in clauses
(i)and (ii). > > > #### “(3) Procedure > > In promulgating regulations under this subsection, the Secretary shall issue a notice of proposed rulemaking that includes a copy of the proposed regulation, provide a period of not less than 60 calendar days for comments on the proposed regulation, and publish the final regulation not less than 30 calendar days before the effective date of the regulation. > > > #### “(4) Restrictions > > Notwithstanding any other provision of law, the Secretary shall promulgate regulations implementing this section only as described in paragraphs (1), (2), and (3). > > > #### “(5) Final regulations > > The Secretary shall finalize the regulations under this section not later than 27 months after the date of enactment of the Sunscreen Innovation Act.” > .
Connectionstraces to 1
Citation graph
cites case law
Sec. 3
NON-SUNSCREEN TIME AND EXTENT APPLICATIONS
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.